Evidence map›Paper›PMID 18438404›Full record

ArticleNature chemical biology2008

Activation of the endocannabinoid system by organophosphorus nerve agents.

Daniel K Nomura, Jacqueline L Blankman, Gabriel M Simon, Kazutoshi Fujioka, Roger S Issa, Anna M Ward, Benjamin F Cravatt, John E Casida

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 113 citations in OpenAlex.

  1. Metabolism of host lysophosphatidylcholine inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Article
  3. Article
  4. Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells.Toxicology in vitro : an international journal published in association with BIBRA · 2022
    Article
  5. Use of computational toxicology tools to predictCurrent research in toxicology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inhibition of cholinergic and non-cholinergic targets following subacute exposure to chlorpyrifos in normal and high fat fed male C57BL/6J mice.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  13. Review
  14. Endocannabinoids and relatedInflammation and regeneration · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. WWL70 attenuates PGEJournal of neuroinflammation · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel K NomuraEnvironmental Chemistry and Toxicology Laboratory, Department of Environmental Science, Policy and Management, University of California, 114 Wellman Hall, Berkeley, California 94720-3112, USA.
Jacqueline L Blankman
Gabriel M Simon
Kazutoshi Fujioka
Roger S Issa
Anna M Ward
Benjamin F Cravatt
John E Casida
University of California, Berkeley · USScripps Research Institute · US

Funding

Chemical Approaches for Activity-Based ProteomicsR37CA087660 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2009 to 2018
$3.1M
CHEMICAL APPROACHES FOR ACTIVITY BASED PROTEOMICSR01CA087660 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2000 to 2008
$2.8M
Organophosphorus Pesticide ToxicologyR01ES008762 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CASIDA, JOHN E · 1998 to 2006
$1.7M
NCI NIH HHS CA087660NCI NIH HHS R01 CA087660NCI NIH HHS R37 CA087660NIEHS NIH HHS ES008762NIEHS NIH HHS R01 ES008762
6 · The paper itself

Abstract

Delta(9)-tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, has useful medicinal properties but also undesirable side effects. The brain receptor for THC, CB(1), is also activated by the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). Augmentation of endocannabinoid signaling by blockade of their metabolism may offer a more selective pharmacological approach compared with CB(1) agonists. Consistent with this premise, inhibitors of the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH) produce analgesic and anxiolytic effects without cognitive defects. In contrast, we show that dual blockade of the endocannabinoid-degrading enzymes monoacylglycerol lipase (MAGL) and FAAH by selected organophosphorus agents leads to greater than ten-fold elevations in brain levels of both 2-AG and anandamide and to robust CB(1)-dependent behavioral effects that mirror those observed with CB(1) agonists. Arachidonic acid levels are decreased by the organophosphorus agents in amounts equivalent to elevations in 2-AG, which indicates that endocannabinoid and eicosanoid signaling pathways may be coordinately regulated in the brain.

Indexed as

EndocannabinoidsAmidohydrolasesAnimalsArachidonic AcidArachidonic AcidsBrainCannabinoid Receptor ModulatorsFatty Acid Amide HydrolasesFemaleGlyceridesMaleMiceMice, Inbred C57BLMice, KnockoutMolecular ConformationMonoacylglycerol LipasesAmidohydrolasesanandamideArachidonic AcidArachidonic AcidsCannabinoid Receptor ModulatorsEndocannabinoidsFatty Acid Amide HydrolasesGlyceridesglyceryl 2-arachidonateMonoacylglycerol LipasesOrganophosphorus CompoundsPolyunsaturated AlkamidesReceptor, Cannabinoid, CB1Receptors, Cannabinoid

Identifiers

PMID18438404
PMCPMC2597283
OpenAlexW2081242345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.